Mateon Therapeutics
Mateon Therapeutics completes acquisition of PointR Data
Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung Therapy Combined AI 360 platform for respiratory wellness - The Statesman
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma
FinData: Share Price for NASDAQ, MATN - Mateon Therapeutics Inc.
NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts | Justia
COVID Pandemic Hastens Search For New Technology And CRO Partner
Zacks Small-Cap Research
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia
Mateon Therapeutics - BIO Investor Forum | BIO
Mateon Therapeutics Company Profile: Valuation, Investors, Acquisition | PitchBook
Consulting Agreement by and between the Company and Artius, | MATEON THERAPEUTICS INC | Business Contracts | Justia
EX-4.1
Mateon Therapeutics
Windlas Biotech, Mateon Therapeutics launch integrated solution for respiratory wellness in India
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Mateon | HealthWire
DEVELOPMENT UPDATE FOR ARTIVEDA™/ARTISHIELD™ AGAINST
Mateon Therapeutics Archives - IndiaMedToday
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
Mateon and PointR to merge into AI-driven oncology firm
Windlas Biotech and Mateon Therapeutics to launch combined lung therapy, AI Telemedicine solution - Express Healthcare
A Covid-19 treatment plan slowly emerges | Evaluate
